Most men who undergo radiation therapy (RT) for prostate cancer will develop anejaculation, a new study shows.
SAN FRANCISCO—New research implicates erectile dysfunction (ED) as an independent risk factor for high-risk coronary artery calcification.
SAN FRANCISCO—Researchers have identified medical conditions that are independently associated with moderate to severe urinary incontinence (UI) in men. These include major depression, hypertension, and prostatic enlargement.
SAN FRANCISCO—Nocturia, defined as two or more urinations per night, is associated with an increased risk of death, even after adjusting for comorbidities known to increase mortality, according to two new studies presented at the American Urological Association annual meeting.
SAN FRANCISCO—Men with diabetes experience significantly smaller increases in PSA level as they age compared with non-diabetics, according to findings reported here at the American Urological Association Annual Meeting.
SAN FRANCISCO—Urine levels of prostate cancer gene 3 (PCA3) can more specifically predict the presence of prostate cancer than PSA levels, according to new findings.
SAN FRANCISCO—Among obese white men, those with diabetes mellitus (DM) are more likely than non-diabetics to have high-grade prostate cancer discovered on prostate biopsy, according to researchers.
SAN FRANCISCO—Prostate biopsies performed after treatment with 5-alpha reductase inhibitors increase the rate of prostate cancer detection, researchers reported at the American Urological Association annual meeting.
SAN FRANCISCO—Dogs can be trained to detect prostate cancer by smelling urine samples and signaling the presence of certain volatile organic compounds (VOCs) produced by cancer cells, according to French researchers.
SAN FRANCISCO—Finasteride and dutasteride are similarly effective for treating lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia in properly selected patients, but dutasteride is associated with significantly greater sexual side effects and breast complications, researchers reported.
SAN FRANCISCO—Pivotal clinical trials of a novel treatment for premature ejaculation (PE) have yielded promising results, a researcher announced here at a press conference during the American Urological Association annual meeting.
SAN FRANCISCO—Nearly one in five men who undergo radical prostatectomy (RP) for high-risk prostate cancer experience biochemical recurrence (BCR) within two years of surgery, according to the findings of a European study.
SAN FRANCISCO—Prostate cancer patients who have undetectable PSA levels 10 years after undergoing a radical prostatectomy (RP) have a low likelihood of experiencing biochemical recurrence (BCR) of their cancer or of dying from the malignancy, according to researchers.
SAN FRANCISCO—Major depression, hypertension, and prostatic enlargement are independently associated with moderate to severe urinary incontinence (UI) in men aged 40 years and older, according to researchers.
SAN FRANCISCO—Dutasteride treatment may decrease prostatitis-related symptoms, data suggest.
SAN FRANCISCO—Prostate cancer is associated with significantly increased urinary bother in community-dwelling older men with lower urinary tract symptoms (LUTS), data suggest.
SAN FRANCISCO—Men with low-risk prostate cancer who delay undergoing radical prostatectomy (RP) for six months or more after diagnosis may have worse outcomes post-operatively than those who undergo RP within six months, according to researchers.
SAN FRANCISCO—Radical prostatectomy (RP) is associated with significantly better intermediate-term survival than radiation treatment among men with clinically localized prostate cancer, data suggest.
SAN FRANCISCO—Increasing levels of C-reactive protein (CRP) are associated with increasing odds of overactive bladder (OAB), according to a population-based study of men and women.
SAN FRANCISCO—Men who undergo three-dimensional external beam radiotherapy (3D-EBRT) for prostate cancer may be at elevated risk for hip fractures, according to researchers.
Researchers have developed a standardized scoring system for quantifying renal tumor size, location, and depth.
Injecting autologous muscle-derived cells (AMDCs) into the bladder may significantly improve symptoms and quality of life (QOL) in patients with stress urinary incontinence (SUI), according to Canadian researchers.
Pomegranate juice may help slow progression of prostate cancer in men who experience rising PSA levels following radical prostatectomy or radiotherapy, data suggest.
CHICAGO—Dutasteride lowers the risk of prostate cancer by 23% in men with an increased risk of the malignancy, new findings show.
Heart disease is significantly more prevalent in older white women with a history of kidney stones than in those who have never had a kidney stone, new findings suggest.
PSA density (PSAD) predicts pathologic upstaging following radical prostatectomy (RP) for prostate cancer, a study found.
Use of the Modification of Diet in Renal Disease (MDRD) study formula may overestimate the number patients with renal dysfunction, according to researchers at the Roswell Park Cancer Institute in Buffalo.
CHICAGO—Sipuleucel-T (Provenge), an experimental immunotherapeutic vaccine, prolonged survival in men with metastatic, androgen-independent prostate cancer, according to study findings presented here at the American Urological Association annual meeting.
CHICAGO—The American Urological Association (AUA) recommends that PSA testing should be offered to well-informed men aged 40 years and older who have a life expectancy of at least 10 years.
- Polycystic Kidney Disease Raises Atrial Fibrillation Risk
- Protein Ups Glucose-lowering Effect of Vildagliptin in Diabetes
- PCa Expectant Management Linked With Veterans' Age, Tumor Risk
- Vitamin D Treatment Does Not Improve Prediabetes
- Using Telemedicine for Patient Encounters: One Urologist's Experience
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)